These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 30414477)

  • 21. Development of reconstitutable suspensions containing diclofenac sodium-loaded microspheres for pediatric delivery.
    Oz UC; Devrim B; Bozkır A; Canefe K
    J Microencapsul; 2015; 32(4):317-28. PubMed ID: 26154114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Orodispersible films and tablets with prednisolone microparticles.
    Brniak W; Maślak E; Jachowicz R
    Eur J Pharm Sci; 2015 Jul; 75():81-90. PubMed ID: 25889975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Film-coated matrix mini-tablets for the extended release of a water-soluble drug.
    Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2015 Apr; 41(4):623-30. PubMed ID: 24564797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged-release minitablets with carbamazepine - preliminary observations in vitro.
    Dzajkowska M; Hanna K; Anna M; Maja S; Dagmara D; Anna S; Malgorzata S
    J Pharm Pharmacol; 2017 Apr; 69(4):471-479. PubMed ID: 28000299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disintegration time of orally dissolving films: various methodologies and
    Saab M; Mehanna MM
    Pharmazie; 2019 Apr; 74(4):227-230. PubMed ID: 30940306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, development and in-vitro evaluation of diclofenac taste-masked orodispersible tablet formulations.
    Guhmann M; Preis M; Gerber F; Pöllinger N; Breitkreutz J; Weitschies W
    Drug Dev Ind Pharm; 2015 Apr; 41(4):540-51. PubMed ID: 24495274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new melatonin oral delivery platform based on orodispersible films containing solid lipid microparticles.
    Musazzi UM; Dolci LS; Albertini B; Passerini N; Cilurzo F
    Int J Pharm; 2019 Mar; 559():280-288. PubMed ID: 30690132
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
    Lin SY; Lin KH; Li MJ
    J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous manufacturing and analytical characterization of fixed-dose, multilayer orodispersible films.
    Thabet Y; Lunter D; Breitkreutz J
    Eur J Pharm Sci; 2018 May; 117():236-244. PubMed ID: 29499348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and evaluation of matrix-based controlled release tablets of diclofenac sodium and chondroitin sulphate.
    Avachat A; Kotwal V
    AAPS PharmSciTech; 2007 Oct; 8(4):E88. PubMed ID: 18181548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative study of drug release from pellets coated with HPMC or Surelease.
    Sadeghi F; Ford JL; Rubinstein MH; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2000 Jun; 26(6):651-60. PubMed ID: 10826113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of novel diclofenac potassium controlled release tablets by wet granulation technique and the effect of co-excipients on in vitro drug release rates.
    Shah S; Khan GM; Jan SU; Shah K; Hussain A; Khan H; Khan H; Khan H; Khan KA
    Pak J Pharm Sci; 2012 Jan; 25(1):161-8. PubMed ID: 22186325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controlled-release cellulose esters matrices for water-soluble diclofenac sodium: compression and dissolution studies.
    Obeidat WM; Alzoubi NM
    Pharmazie; 2014 Feb; 69(2):96-103. PubMed ID: 24640597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poly vinyl acetate and ammonio methacrylate copolymer as unconventional polymer blends increase the mechanical robustness of HPMC matrix tablets.
    Ali R; Dashevsky A; Bodmeier R
    Int J Pharm; 2017 Jan; 516(1-2):3-8. PubMed ID: 27818241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formulation Optimization and in Vitro Characterization of Orally Disintegrating Films Using a Factorial Design and Mathematical Modeling for Drug Release.
    Lee Y; Thapa P; Jeong SH; Woo MH; Choi DH
    Chem Pharm Bull (Tokyo); 2017 Feb; 65(2):166-177. PubMed ID: 27904030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and characterization of an orodispersible film containing drug nanoparticles.
    Shen BD; Shen CY; Yuan XD; Bai JX; Lv QY; Xu H; Dai L; Yu C; Han J; Yuan HL
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1348-56. PubMed ID: 24103635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of casting solvent, film-forming agent and solubilizer on orodispersible films of a polymorphic poorly soluble drug: an
    El-Bary AA; Al Sharabi I; Haza'a BS
    Drug Dev Ind Pharm; 2019 Nov; 45(11):1751-1769. PubMed ID: 31416366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Applying a novel electrostatic dry powder coating technology to pellets.
    Yang Q; Ma Y; Zhu J
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):118-24. PubMed ID: 26478275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of gellan gum containing formulations for transdermal drug delivery: Component evaluation and controlled drug release using temperature responsive nanogels.
    Carmona-Moran CA; Zavgorodnya O; Penman AD; Kharlampieva E; Bridges SL; Hergenrother RW; Singh JA; Wick TM
    Int J Pharm; 2016 Jul; 509(1-2):465-476. PubMed ID: 27260133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality by design approach for optimizing the formulation and physical properties of extemporaneously prepared orodispersible films.
    Visser JC; Dohmen WM; Hinrichs WL; Breitkreutz J; Frijlink HW; Woerdenbag HJ
    Int J Pharm; 2015 May; 485(1-2):70-6. PubMed ID: 25746737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.